Total Payments
$7,740
2024 Payments
$28.31
Companies
18
Transactions
146
Payment Breakdown by Category
Other$5,304 (68.5%)
Food & Beverage$2,429 (31.4%)
Education$6.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $5,304 | 1 | 68.5% |
| Food and Beverage | $2,429 | 143 | 31.4% |
| Education | $6.93 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $5,387 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $520.04 | 30 | $0 (2019) |
| Alkermes, Inc. | $417.71 | 11 | $0 (2023) |
| Shire North American Group Inc | $376.34 | 30 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $366.23 | 22 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $237.26 | 19 | $0 (2018) |
| Allergan Inc. | $119.93 | 9 | $0 (2019) |
| Lundbeck LLC | $47.38 | 3 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $44.43 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.52 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.31 | 1 | Teva Pharmaceuticals USA, Inc. ($28.31) |
| 2023 | $5,470 | 4 | Neuronetics, Inc. ($5,304) |
| 2022 | $52.24 | 3 | Alkermes, Inc. ($37.42) |
| 2021 | $119.26 | 1 | Alkermes, Inc. ($119.26) |
| 2019 | $324.20 | 20 | Allergan Inc. ($84.15) |
| 2018 | $881.97 | 59 | Otsuka America Pharmaceutical, Inc. ($265.17) |
| 2017 | $864.48 | 58 | Otsuka America Pharmaceutical, Inc. ($241.33) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Neurology | ||||||
| 09/30/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Neurology | ||||||
| 09/13/2023 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $5,304.24 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 05/02/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $41.26 | General |
| Category: Neuroscience | ||||||
| 03/23/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $107.93 | General |
| Category: CNS | ||||||
| 12/14/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Neuroscience | ||||||
| 02/16/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CNS | ||||||
| 02/01/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: CNS | ||||||
| 12/08/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $119.26 | General |
| Category: CNS | ||||||
| 05/30/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: PSYCHIATRY | ||||||
| 04/29/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CNS | ||||||
| 04/22/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Neuroscience | ||||||
| 03/21/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Neuroscience | ||||||
| 03/18/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.71 | General |
| Category: PSYCHIATRY | ||||||
| 03/04/2019 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: BH | ||||||
| 03/01/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: CNS | ||||||
| 02/25/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Victor Oderinde, M.D
Dr. Victor Oderinde, M.D is a Child & Adolescent Psychiatry healthcare provider based in Spring, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861486482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Victor Oderinde, M.D has received a total of $7,740 in payments from pharmaceutical and medical device companies, with $28.31 received in 2024. These payments were reported across 146 transactions from 18 companies. The most common payment nature is "Debt forgiveness" ($5,304).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Spring, TX
- Active Since 09/09/2005
- Last Updated 04/18/2008
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1861486482
Products in Payments
- NEUROSTAR TMS THERAPY SYSTEM (Device) $5,304
- REXULTI (Drug) $357.80
- LATUDA (Drug) $237.26
- INVEGA SUSTENNA (Drug) $236.29
- LYBALVI (Drug) $227.19
- VYVANSE (Drug) $220.52
- ABILIFY MAINTENA (Drug) $209.62
- MYDAYIS (Drug) $155.82
- VRAYLAR (Drug) $119.93
- ARISTADA (Drug) $96.18
- Vivitrol 380 mg (Drug) $69.73
- NeuroStar TMS Therapy (Device) $68.02
- Trintellix (Drug) $67.91
- UZEDY (Drug) $44.43
- Adzenys XR-ODT (Drug) $37.02
- SPRAVATO (Drug) $32.85
- VIVITROL (Drug) $24.61
- METHYLPHENIDATE 72 (Drug) $21.38
- INVEGA TRINZA (Drug) $18.85
- PERSERIS (Drug) $17.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Spring
Dr. John Steffek, Md, MD
Child & Adolescent Psychiatry — Payments: $14,455
Child & Adolescent Psychiatry $14,455
Olayinka Ayeni, Md, MD
Child & Adolescent Psychiatry — Payments: $1,284
Child & Adolescent Psychiatry $1,284
Dr. Vishnu Challapalli, M.d, M.D
Child & Adolescent Psychiatry — Payments: $257.22
Child & Adolescent Psychiatry $257.22